TMO vs XOM: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
VS
Exxon Mobil Corporation · Energy
$154.46
-37.3% upside to fair value
Grade C
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
XOM trades at a lower forward P/E
(23.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
XOM |
| Current Price |
$462.60 |
$154.46 |
| Fair Value Estimate |
$509.20 |
$96.85 |
| Upside to Fair Value |
+10.1%
|
-37.3%
|
| Market Cap |
$171.9B |
$642.0B |
| Forward P/E |
25.1x
|
23.2x
|
| EV / EBITDA |
19.0x
|
10.3x
|
| Price / Sales |
3.8x
|
2.0x
|
| Price / FCF |
25.5x
|
27.2x
|
| Revenue Growth YoY |
+6.2%
|
-1.3%
|
| Gross Margin |
39.4%
|
21.7%
|
| Operating Margin |
17.8%
|
10.5%
|
| Return on Equity |
13.3%
|
11.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.92%
|
3.68%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Exxon Mobil Corporation operates as a global integrated oil and gas company with significant operations in upstream, energy products, chemical products, and specialty products segments. The company benefits from a highly experienced management team with decades of internal tenure, led by CEO Darren Woods. Despite strong cash flow generation and operational scale, Exxon is currently overvalued, tr…
Accumulation Zones
| Metric |
TMO |
XOM |
| Zone Low |
$381.90 |
$72.64 |
| Zone High |
$432.82 |
$82.32 |
| In Buy Zone? |
No
|
No
|